Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 18Bone Neoplasms 9Osteosarcoma 8Sarcoma, Kaposi 4Neoplasms 2Gastrointestinal Stromal Tumors 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an 1Teratoma 1Stomatitis 1Soft Tissue Neoplasms 1Risk Reduction Behavior 1Rhabdomyosarcoma 1Recurrence 1Prosthesis-Related Infections 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms, Muscle Tissue 1Neoplasms, Connective and Soft Tissue 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Melanoma 1Margins of Excision 1Lymphoma 1Lung Neoplasms 1Liposarcoma, Myxoid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Risk Reduction Behavior × Sarcoma × Clear all
NCT06968884 2025-05-13

Application of a Comprehensive Protocol Aimed at Reducing the Risk of Complications After Surgery for Sarcoma. Interventions Before, During and After Surgery for Known and Presumed Risk Factors Compared to Standard of Care in a Total of 300 Patients.

Region Stockholm

Phase NA Enrolling by invitation
300 enrolled
Sarcoma

Sarcoma, Risk Reduction Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡